Fonte: CJC Open. Unidade: EERP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), ESTUDOS RETROSPECTIVOS, UNIDADES DE CUIDADOS CORONARIANOS
ABNT
DJIOKENG, Laura Blonde Guefack et al. Impact of Vanessa's law on the reporting of serious adverse events: a retrospective study among antiplatelet users in a tertiary-care cardiology centre. CJC Open, v. 6, n. 12, p. 1527-1533, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.cjco.2024.09.003. Acesso em: 26 out. 2025.APA
Djiokeng, L. B. G., Todkar, S., Corbin, S., Lavallée, M., Pradhan, P., Thibault, M., et al. (2024). Impact of Vanessa's law on the reporting of serious adverse events: a retrospective study among antiplatelet users in a tertiary-care cardiology centre. CJC Open, 6( 12), 1527-1533. doi:10.1016/j.cjco.2024.09.003NLM
Djiokeng LBG, Todkar S, Corbin S, Lavallée M, Pradhan P, Thibault M, Piché M-E, Méthot J, Bérard A, Gonella JM, Sousa FREG de, Darveau R, Cloutier I, Leclerc J. Impact of Vanessa's law on the reporting of serious adverse events: a retrospective study among antiplatelet users in a tertiary-care cardiology centre [Internet]. CJC Open. 2024 ; 6( 12): 1527-1533.[citado 2025 out. 26 ] Available from: https://doi.org/10.1016/j.cjco.2024.09.003Vancouver
Djiokeng LBG, Todkar S, Corbin S, Lavallée M, Pradhan P, Thibault M, Piché M-E, Méthot J, Bérard A, Gonella JM, Sousa FREG de, Darveau R, Cloutier I, Leclerc J. Impact of Vanessa's law on the reporting of serious adverse events: a retrospective study among antiplatelet users in a tertiary-care cardiology centre [Internet]. CJC Open. 2024 ; 6( 12): 1527-1533.[citado 2025 out. 26 ] Available from: https://doi.org/10.1016/j.cjco.2024.09.003





